AMGN
AMGEN INC
Key Financials
Operating Income
$9.1B
↑ 25.1%
Net Income
$7.7B
↑ 88.5%
Gross Profit
$4.7B
↑ 4.3%
Revenue
$36.8B
↑ 10.0%
Total Assets
$90.6B
↓ 1.4%
EPS (Diluted)
$14.23
↑ 88.2%
Shareholders' Equity
$8.7B
↑ 47.3%
Cash & Equivalents
$9.1B
↓ 23.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AMGN |
| Company Name | AMGEN INC |
| CIK | 318154 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (805)447-1000 |